ストックスクリーナーアプリを入手
54.96
1.99%
1.07
プレマーケット:
54.71
-0.25
-0.45%
Cytokinetics Inc (CYTK) 最新ニュース
Cytokinetics, Inc. Experiences Evaluation Revision Amidst Evolving Market Dynamics - Markets Mojo
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, - GlobeNewswire
Insider Sell Alert: Kaye Edward M. MD Sells Shares of Cytokineti - GuruFocus
Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI that Class Action Lawsuits Have Been Filed and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm - MarketScreener
Cytokinetics, Incorporated Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCYTK - MarketScreener
Shareholders SueWallSt in New Class Action Against Cytokinetics, IncorporatedAct Now - Nasdaq
Should I hold or sell Cytokinetics Incorporated stock in 20252025 Market WrapUp & Weekly Chart Analysis and Guides - newser.com
Why Cytokinetics Incorporated (KK3A) stock appears on watchlistsQuarterly Profit Report & Capital Efficiency Focused Strategies - newser.com
Stock Traders Purchase High Volume of Cytokinetics Call Options (NASDAQ:CYTK) - Defense World
CYTK Stockholders With Large Losses Should Contact Robbins LLP For Information About The Cytokinetics, Inc. Securities Fraud Class Action - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Cytokinetics, Incorporated (CYTK) Investors of November 17, 2025 Deadline - ACCESS Newswire
HC Wainwright & Co. Reiterates Cytokinetics (CYTK) Buy Recommendation - Nasdaq
Cytokinetics Incorporated (CYTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Shareholders who lost money in shares of Cytokinetics, - GlobeNewswire
How Cytokinetics Incorporated stock benefits from tech adoptionJuly 2025 Review & Long Hold Capital Preservation Plans - newser.com
Cytokinetics, Incorporated Securities Lawsuit Investigation - Claim Depot
Cytokinetics (CYTK) Receives Reiterated 'Buy' Rating with $120 T - GuruFocus
Cytokinetics (NASDAQ:CYTK) Earns "Buy" Rating from HC Wainwright - MarketBeat
Published on: 2025-09-29 10:40:49 - newser.com
Investors Buy Large Volume of Cytokinetics Call Options (NASDAQ:CYTK) - MarketBeat
Can Cytokinetics Incorporated (KK3A) stock sustain breakout momentumJuly 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Strategies to average down on Cytokinetics IncorporatedJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Should I buy Cytokinetics Incorporated (KK3A) stock before earnings seasonGDP Growth & Safe Entry Trade Reports - newser.com
Cytokinetics (CYTK) Reveals Promising Aficamten Data at Heart Fa - GuruFocus
Class Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Cytokinetics presents new data related to aficamten - MarketScreener
Cytokinetics Announces Positive Data on Aficamten's Impact on Exercise Capacity and Long-Term Efficacy at HFSA Annual Scientific Meeting 2025 - Quiver Quantitative
Cytokinetics Presents New Data Related To Aficamten - TradingView
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 - Yahoo Finance
Cytokinetics Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Lost Money on Cytokinetics, Incorporated (CYTK)? Contact Levi & Korsinsky to Join Class Action Before November 17, 2025 - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming DeadlinesCYTK - PR Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel - Caledonian Record
What drives Cytokinetics Incorporated KK3A stock priceMarket Sentiment Indicators & Small Entry Cost Trading - earlytimes.in
Can Cytokinetics Incorporated (KK3A) stock expand revenue streamsRate Cut & Daily Profit Maximizing Trade Tips - newser.com
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, I - PR Newswire
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) InvestorsContact Levi & Korsinsky Before November 17, 2025 - ACCESS Newswire
Class Action Filed Against Cytokinetics, Incorporated (CYTK)November 17, 2025 Deadline to JoinContact Levi & Korsinsky - Morningstar
Published on: 2025-09-26 01:51:19 - newser.com
November 17, 2025 Deadline Approaching: Join Class Action Against Cytokinetics, Incorporated (CYTK)Contact Levi & Korsinsky - Newsfile
Deadline Alert: Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire
CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Faruqi & Faruqi Reminds Cytokinetics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 17, 2025CYTK | FinancialContent - FinancialContent
Shareholders that lost money on Cytokinetics, Incorporated(CYTK) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):